Registration Strip Icon for monitor 브라질 증권 거래소, NASDAQ, NYSE, AMEX, LSE 등 주요 거래소에서의 다양한 실시간 주식 시세를 모니터링합니다.

ARTH

Arch Therapeutics (QB) (ARTH)

Arch Therapeutics Inc (QB)
일자:
정렬 기준:
 검색 관련기사 보기:USOTC:ARTH
일자시간출처헤드라인심볼기업
2023/06/2305:31Edgar (US Regulatory)Current Report Filing (8-k)USOTC:ARTHArch Therapeutics Inc (QB)
2023/05/2319:02Edgar (US Regulatory)Quarterly Report (10-q)USOTC:ARTHArch Therapeutics Inc (QB)
2023/05/1619:01Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)USOTC:ARTHArch Therapeutics Inc (QB)
2023/04/2105:07Edgar (US Regulatory)Current Report Filing (8-k)USOTC:ARTHArch Therapeutics Inc (QB)
2023/03/1719:04Edgar (US Regulatory)Current Report Filing (8-k)USOTC:ARTHArch Therapeutics Inc (QB)
2023/03/0922:08Edgar (US Regulatory)Current Report Filing (8-k)USOTC:ARTHArch Therapeutics Inc (QB)
2023/03/0723:01Edgar (US Regulatory)Current Report Filing (8-k)USOTC:ARTHArch Therapeutics Inc (QB)
2023/02/1620:05Edgar (US Regulatory)Current Report Filing (8-k)USOTC:ARTHArch Therapeutics Inc (QB)
2023/02/1506:48Edgar (US Regulatory)Quarterly Report (10-q)USOTC:ARTHArch Therapeutics Inc (QB)
2023/01/2605:19Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)USOTC:ARTHArch Therapeutics Inc (QB)
2023/01/2407:18Edgar (US Regulatory)Securities Registration Statement (s-1/a)USOTC:ARTHArch Therapeutics Inc (QB)
2023/01/1806:31Edgar (US Regulatory)Current Report Filing (8-k)USOTC:ARTHArch Therapeutics Inc (QB)
2022/12/2906:52Edgar (US Regulatory)Annual Report (10-k)USOTC:ARTHArch Therapeutics Inc (QB)
2022/12/0221:26Edgar (US Regulatory)Current Report Filing (8-k)USOTC:ARTHArch Therapeutics Inc (QB)
2022/10/0105:37Edgar (US Regulatory)Current Report Filing (8-k)USOTC:ARTHArch Therapeutics Inc (QB)
2022/08/3119:05Edgar (US Regulatory)Notice of Effectiveness (effect)USOTC:ARTHArch Therapeutics Inc (QB)
2022/08/3106:21Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(4) (424b4)USOTC:ARTHArch Therapeutics Inc (QB)
2022/08/3019:02Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)USOTC:ARTHArch Therapeutics Inc (QB)
2022/08/2619:09Edgar (US Regulatory)Securities Registration Statement (s-1/a)USOTC:ARTHArch Therapeutics Inc (QB)
2022/08/2219:04Edgar (US Regulatory)Securities Registration Statement (s-1)USOTC:ARTHArch Therapeutics Inc (QB)
2022/08/1819:03Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)USOTC:ARTHArch Therapeutics Inc (QB)
2022/08/1805:11Edgar (US Regulatory)Amended Current Report Filing (8-k/a)USOTC:ARTHArch Therapeutics Inc (QB)
2022/08/1605:24Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)USOTC:ARTHArch Therapeutics Inc (QB)
2022/08/1605:21Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)USOTC:ARTHArch Therapeutics Inc (QB)
2022/08/1605:03Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)USOTC:ARTHArch Therapeutics Inc (QB)
2022/08/1206:24Edgar (US Regulatory)Quarterly Report (10-q)USOTC:ARTHArch Therapeutics Inc (QB)
2022/07/1206:26Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)USOTC:ARTHArch Therapeutics Inc (QB)
2022/07/1206:25Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)USOTC:ARTHArch Therapeutics Inc (QB)
2022/07/1206:25Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)USOTC:ARTHArch Therapeutics Inc (QB)
2022/07/0906:01Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:ARTHArch Therapeutics Inc (QB)
 검색 관련기사 보기:USOTC:ARTH